These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3150783)

  • 1. [Clinical pharmacology of flecainide].
    Rewerski W; Walczak F; Nyznyk M; Dorociak A; Skorupska U
    Pol Tyg Lek; 1988 Sep; 43(36):1161-5. PubMed ID: 3150783
    [No Abstract]   [Full Text] [Related]  

  • 2. Flecainide: a new antiarrhythmic agent.
    Nestico PF; Morganroth J
    Am Fam Physician; 1986 Nov; 34(5):197-200. PubMed ID: 2430440
    [No Abstract]   [Full Text] [Related]  

  • 3. The clinical pharmacology of antiarrhythmic drugs.
    Adams PC; Campbell RW; Julian DG
    Cardiovasc Clin; 1984; 14(3):153-90. PubMed ID: 6722851
    [No Abstract]   [Full Text] [Related]  

  • 4. Proarrhythmic and antiarrhythmic effects of flecainide on nonsustained reentry around the canine atrial tricuspid ring in vitro.
    Frame LH; Rhee EK; Fei H; Luchetti W
    Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 2):1728-34. PubMed ID: 1721165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric flecainide toxicity from a double dose.
    Close BR; Banks CJ
    Am J Emerg Med; 2012 Nov; 30(9):2095.e1-2. PubMed ID: 22386360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flecainide: its value and danger.
    Malik R; Ellenbogen KA; Stambler BS; Wood MA
    Heart Dis Stroke; 1994; 3(2):85-9. PubMed ID: 8199770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
    Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of intravenous flecainide in the treatment of acute ventricular arrhythmia].
    Aliot E; Baille N; Zannad F; Gilgenkrantz JM
    Ann Cardiol Angeiol (Paris); 1983 Oct; 32(6):417-23. PubMed ID: 6666988
    [No Abstract]   [Full Text] [Related]  

  • 9. Flecainide half-life prolongation in 2 patients with congestive heart failure and complex ventricular arrhythmias.
    Cavalli A; Maggioni AP; Marchi S; Volpi A; Latini R
    Clin Pharmacokinet; 1988 Mar; 14(3):187-8. PubMed ID: 3131059
    [No Abstract]   [Full Text] [Related]  

  • 10. Flecainide acetate: critical care administration guidelines.
    Senior S; Baessler C; Monzo M
    Heart Lung; 1988 Jan; 17(1):76-80. PubMed ID: 3123423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An electrophysiologic study on the anti-ischemic arrhythmia effect of flecainide].
    Zha YM
    Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Oct; 16(5):294-7. PubMed ID: 3148452
    [No Abstract]   [Full Text] [Related]  

  • 12. [Electrophysiological effects of the new antiarrhythmic drug flecainide (R 818) in man (author's transl)].
    Seipel L; Abendroth RR; Breithardt G
    Z Kardiol; 1981 Jul; 70(7):524-9. PubMed ID: 7269731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proarrhythmic actions of flecainide in an isolated tissue model of ischemia and reperfusion.
    Heisler BE; Ferrier GR
    J Pharmacol Exp Ther; 1996 Oct; 279(1):317-24. PubMed ID: 8859009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amiodarone: pharmacology, clinical use and side effects].
    Popiliev I
    Vutr Boles; 1985; 24(5):17-25. PubMed ID: 3911581
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of ventricular arrhythmias.
    Fogoros RN
    Am Fam Physician; 1986 Mar; 33(3):236-46. PubMed ID: 3953344
    [No Abstract]   [Full Text] [Related]  

  • 16. [Arrhythmias of ectopic origin: the physiopathological bases for their treatment].
    Vassalle M
    Arch Inst Cardiol Mex; 1991; 61(5):455-63. PubMed ID: 1772319
    [No Abstract]   [Full Text] [Related]  

  • 17. [Injectable diphenylhydantoin in cardiology. Experimental study].
    Quiret JC; Bens JL; Duboisset M; Lesbre P; Bernasconi P
    Arch Mal Coeur Vaiss; 1974 Jan; 67(1):87-96. PubMed ID: 4211204
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antiarrhythmic therapy with flecainide in acute experimental myocardial infarction (author's transl)].
    Gülker H; Bender F; Brisse B; Thale J; Heuer H; Kristek J; Schindelhauer F; Teerling K
    Z Kardiol; 1981 Feb; 70(2):124-30. PubMed ID: 7222906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias.
    Gettes LS
    Cardiovasc Clin; 1970; 2(2):211-37. PubMed ID: 4149974
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental and clinical pharmacology of cardiac arrhythmias.
    Haas HH
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 269(2):173-7. PubMed ID: 4254276
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.